يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"de Mendoza FH"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.

    المؤلفون: Pettengell R, Coiffier B, Narayanan G, de Mendoza FH, Digumarti R, Gomez H, Schiller G, Rizzieri D, Boland G, Cernohous P, Wang L, Kuepfer C, Gorbatchevsky I, Singer J.W., ZINZANI, PIER LUIGI

    المساهمون: Pettengell R, Coiffier B, Narayanan G, de Mendoza FH, Digumarti R, Gomez H, Zinzani P.L., Schiller G, Rizzieri D, Boland G, Cernohous P, Wang L, Kuepfer C, Gorbatchevsky I, Singer JW.

    مصطلحات موضوعية: Pixantrone dimaleate, salvage treatment, refractory aggressive non-Hodgkin lymphoma

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22652183; info:eu-repo/semantics/altIdentifier/wos/WOS:000305955700048; volume:13; firstpage:696; lastpage:706; numberofpages:11; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11585/120207Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84863113681

    الإتاحة: https://doi.org/10.1016/S1470-2045Test(12)70212-7
    http://hdl.handle.net/11585/120207Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

    المؤلفون: Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Pivot XB, Klimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat LT, Roché HH, Thomas, Eva S, Gomez, Henry L, Li, Rubi K

    المصدر: Journal of Clinical Oncology; 11/20/2007, Vol. 25 Issue 33, p5210-5217, 8p


    أضف إلى المفضلة
  3. 3
    Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

    المؤلفون: Paul Cernohous, Bertrand Coiffier, Raghunadharao Digumarti, Fernando Hurtado de Mendoza, David A. Rizzieri, Gary J. Schiller, Ruth Pettengell, Jack W. Singer, Geetha Narayanan, Giles W. Boland, Igor Gorbatchevsky, Henry L. Gomez, Lixia Wang, Pier Luigi Zinzani, Christine Kuepfer

    المساهمون: Pettengell R, Coiffier B, Narayanan G, de Mendoza FH, Digumarti R, Gomez H, Zinzani P.L., Schiller G, Rizzieri D, Boland G, Cernohous P, Wang L, Kuepfer C, Gorbatchevsky I, Singer JW.

    المصدر: The Lancet. Oncology. 13(7)

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, refractory aggressive non-Hodgkin lymphoma, Adolescent, salvage treatment, Population, Salvage therapy, Antineoplastic Agents, Aggressive Non-Hodgkin Lymphoma, Vinorelbine, Ventricular Function, Left, chemistry.chemical_compound, International Prognostic Index, Internal medicine, medicine, Humans, education, Aged, Aged, 80 and over, Salvage Therapy, education.field_of_study, Ifosfamide, Pixantrone, business.industry, Pixantrone dimaleate, Lymphoma, Non-Hodgkin, Middle Aged, Isoquinolines, Surgery, Transplantation, Oncology, chemistry, Female, business, medicine.drug

    وصف الملف: STAMPA

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a49eef91c94b6743ada3711c7585dcf1Test
    https://pubmed.ncbi.nlm.nih.gov/22652184Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث